Farallon Capital Amends Savara Inc. Stake (SC 13G/A)
Ticker: SVRA · Form: SC 13G/A · Filed: Feb 1, 2024 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | SC 13G/A |
| Filed Date | Feb 1, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 20 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, pharmaceuticals, investor-update
TL;DR
**Farallon Capital updated its Savara Inc. stake, signaling a potential shift in institutional interest.**
AI Summary
Farallon Capital Partners, L.P. filed an amended SC 13G/A on February 1, 2024, indicating a change in their beneficial ownership of Savara Inc. common stock as of December 31, 2023. This filing, an Amendment No. 7, updates their previous disclosures regarding their investment in the pharmaceutical preparations company. This matters to investors because it signals a potential shift in a major institutional investor's confidence or strategy regarding Savara Inc., which could influence market perception and stock price.
Why It Matters
Changes in significant institutional holdings can signal shifts in investor confidence, potentially impacting Savara Inc.'s stock price and market sentiment.
Risk Assessment
Risk Level: low — This filing is a routine update on institutional ownership and does not inherently indicate a high-risk event for the company.
Analyst Insight
Investors should monitor subsequent filings from Farallon Capital Partners, L.P. and Savara Inc. to understand the full scope of any changes in ownership and its potential implications for the company's future.
Key Players & Entities
- Farallon Capital Partners, L.P. (company) — the entity filing the SC 13G/A
- Savara Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- February 1, 2024 (date) — the filing date of the SC 13G/A
- $0.001 (dollar_amount) — par value per share of Savara Inc. Common Stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No. 7, as stated in the filing.
Who is the subject company of this filing?
The subject company is Savara Inc., a pharmaceutical preparations company with CIK 0001160308, as identified in the 'SUBJECT COMPANY' section.
Who is the entity that filed this SC 13G/A?
The entity that filed this SC 13G/A is Farallon Capital Partners, L.P., with CIK 0001175707, as indicated in the 'FILED BY' section.
What is the CUSIP number for Savara Inc.'s common stock?
The CUSIP number for Savara Inc.'s Common Stock, par value $0.001 per share, is 805111101, as listed on the cover page of the filing.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified on the cover page.
Filing Stats: 4,929 words · 20 min read · ~16 pages · Grade level 13.4 · Accepted 2024-02-01 15:50:25
Key Financial Figures
- $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securitie
Filing Documents
- svra_13ga.htm (SC 13G/A) — 465KB
- 0000908834-24-000033.txt ( ) — 467KB
From the Filing
SC 13G/A 1 svra_13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7) * Savara Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 805111101 (Cusip Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) S Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (" Act ") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following pages) Page 1 of 35 Pages Exhibit Index Found on Page 34 13G CUSIP No. 805111101 1 NAMES OF REPORTING PERSONS Farallon Capital Partners, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ X ]** ** The reporting persons making this filing hold an aggregate of 6,255,406 Shares (as defined in Item 2) and hold Warrants (as defined in the Preliminary Note) exercisable for an aggregate of 17,940,021 Shares. Due to exercise limitations set forth in the Warrants, as of the date of this filing the reporting persons have the right to exercise Warrants up to an aggregate of 8,071,505 Shares. Accordingly, as of the date of this filing the aggregate Shares and Warrants held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares. The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page. 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION California NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER -0- 6 SHARED VOTING POWER 2,542,599 1 7 SOLE DISPOSITIVE POWER -0- 8 SHARED DISPOSITIVE POWER 2,542,599 1 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,542,599 1 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.9% 1 12 TYPE OF REPORTING PERSON (See Instructions) PN 1 Includes 1,419,510 Shares for which Warrants are exercisable within the next 60 days. Excludes 1,735,545 Shares for which Warrants are not currently exercisable due to the Beneficial Ownership Limitation (as defined in the Preliminary Note). Page 2 of 35 Pages 13G CUSIP No. 805111101 1 NAMES OF REPORTING PERSONS Farallon Capital Institutional Partners, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ X ]** ** The reporting persons making this filing hold an aggregate of 6,255,406 Shares (as defined in Item 2) and hold Warrants (as defined in the Preliminary Note) exercisable for an aggregate of 17,940,021 Shares. Due to exercise limitations set forth in the Warrants, as of the date of this filing the reporting persons have the right to exercise Warrants up to an aggregate of 8,071,505 Shares. Accordingly, as of the date of this filing the aggregate Shares and Warrants held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares. The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page. 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION California NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER -0- 6 SHARED VOTING POWER 3,366,159 1 7 SOLE DISPOSITIVE POWER -0- 8 SHARED DISPOSITIVE POWER 3,366,159 1 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,366,159 1 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.5% 1 12 TYPE OF REPORTING PERSON (See Instructions) PN 1 Includes 2,012,398 Shares for which Warrants are exercisable within the next 60 days. Excludes 2,460,431 Shares for which Warrants are not currently exercisable due to the Beneficial Ownership Limitation (as defined in the Preliminary Note). Page 3 of 35 Pages 13G CUSIP No. 805111101 1 NAMES OF REPORTING PERSONS Farallon Capital Institutional Partners II, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ X ]** ** The reporting persons making this filing hold an aggregate of 6,255,406 Shares (as defined in Item 2) and hold Warrants (as de